Month: May 2023

Erasca to Present Promising Preliminary HERKULES-3 Phase 1b Data at the 2023 ASCO Annual Meeting

Written by Customer Service on May 25, 2023. Posted in Public Companies.

Triplet of ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with metastatic BRAF V600E-mutated colorectal cancer (CRC) showed a 40% (2/5) response rate; continued evaluation of this combination will focus on EC-naïve patients based on promising initial activity ERAS-007 in combination with cell cycle inhibitor palbociclib will not be pursued further in patients with RAS-mutated gastrointestinal (GI) malignancies Erasca to host investor event on June 5, 2023, at 4:30 PM Eastern Time SAN DIEGO, May 25, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced preliminary Phase 1b data for ERAS-007 combinations in patients with...

Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals

Written by Customer Service on May 25, 2023. Posted in Mergers And Acquisitions.

DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined company Combined company will have commercial products and a library of development candidates, including two clinical stage programs DPI-125, the lead development program, is a clinical stage therapeutic under investigation for the treatment of opioid use disorderSAN DIEGO, May 25, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its merger with DMK Pharmaceuticals Corporation. The combined, publicly traded company will focus its efforts on increasing sales of Adamis’ commercial products and advancing DMK’s lead clinical stage compound, DPI-125, which is being studied as a potential novel treatment for opioid use disorder (OUD). The common stock...

Diana Shipping Inc. Announces Special Stock Dividend Distribution Date

Written by Customer Service on May 25, 2023. Posted in Dividend Reports And Estimates.

ATHENS, Greece, May 25, 2023 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that its previously announced special stock dividend payment to common shareholders of record as of April 24, 2023 (the “Record Date”) of an aggregate of 13,157 Series D Convertible Preferred Shares of OceanPal Inc. held by the Company, is now expected to be paid on or around June 9, 2023 (the “Stock Dividend Payment Date”). Other than the revised Stock Dividend Payment Date, no other changes are being made to the terms of the special stock dividend described in the OceanPal Inc. registration statement, including the Record Date and the election deadline. OceanPal Inc. has filed a registration statement with the U.S....

Costco Wholesale Corporation Reports Third Quarter and Year-to-Date Operating Results for Fiscal 2023

Written by Customer Service on May 25, 2023. Posted in Earnings Releases And Operating Results.

ISSAQUAH, Wash., May 25, 2023 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the third quarter (twelve weeks) and the first 36 weeks of fiscal 2023, ended May 7, 2023. Net sales for the quarter increased 1.9 percent, to $52.60 billion, from $51.61 billion last year. Net sales for the first 36 weeks increased 5.5 percent, to $160.28 billion, from $151.97 billion last year. Comparable sales for the third quarter and first 36 weeks of fiscal 2023 were as follows: 12 Weeks 12 Weeks 36 Weeks 36 Weeks Adjusted* Adjusted*U.S. -0.1% 1.8% 4.9% 4.7% Canada -1.0% 7.4% 1.6% 8.4% Other International 4.1% 8.4% 1.6% 9.0% Total Company 0.3% 3.5% 4.0% 5.8% E-commerce -10.0% -9.0% -7.8% -6.6% *Excluding...

23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results

Written by Customer Service on May 25, 2023. Posted in Earnings Releases And Operating Results.

Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, today reported its financial results for the fourth quarter (Q4) and full year of fiscal year 2023 (FY2023), which ended March 31, 2023. 23andMe is the only company with multiple U.S. Food and Drug Administration (FDA) authorizations for over-the-counter genetic health risk reports. The Company has also created the world’s largest, re-contactable crowdsourced platform of genotypic information paired with billions of phenotypic data points contributed...

Kane Biotech Announces First Quarter 2023 Financial Results

Written by Customer Service on May 25, 2023. Posted in Earnings Releases And Operating Results.

WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced its first quarter 2023 financial results. First Quarter Financial Highlights:Total revenue for the three months ended March 31, 2023, was $677,617, an increase of 20% compared to $565,433 in the three months ended March 31, 2022.License and royalty revenue for the three months ended March 31, 2023 was $138,180, an increase of 66% compared to $83,349 in the three months ended March 31, 2022.Revenue from product and services sales for the three months ended March 31, 2023 was $539,437, an increase of 12% from $482,084 in the three...

Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China

Written by Customer Service on May 25, 2023. Posted in Public Companies.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm’s subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in NASH Sino Biopharm will participate in the ongoing NATiV3 Phase III trial which, if positive, is expected to support a potential NDA filing in China In parallel, Sino Biopharm will conduct a Phase I clinical pharmacology study Following this regulatory decision, Inventiva is eligible to the first of the 2 short term milestones amounting to a total of $5 million, under the license and collaboration agreement with CTTQ Daix (France), Long Island City (New York, United States), Beijing/Hong Kong (China), May 25, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule...

Summit Financial Group, Inc. Announces Q2 Common Dividend of $0.20 Per Share

Written by Customer Service on May 25, 2023. Posted in Dividend Reports And Estimates.

MOOREFIELD, W.Va., May 25, 2023 (GLOBE NEWSWIRE) — Summit Financial Group, Inc. (“Summit”) (NASDAQ: SMMF) announces its Board of Directors recently declared a second quarter 2023 dividend of $0.20 per share payable on June 30, 2023 to common shareholders of record as of the close of business on June 15, 2023. Summit Financial Group, Inc. is the $4.5 billion financial holding company for Summit Community Bank, Inc. Its talented bankers serve commercial and individual clients throughout West Virginia, the Washington, D.C. metropolitan area, Virginia, Kentucky, Eastern Shore of Maryland and Delaware. Summit’s focus on in-market commercial lending and providing other business banking services in dynamic markets is designed to leverage its highly efficient operations and core deposits in strong legacy locations. Residential and consumer...

eWorld Companies, Inc. Releases Detailed Shareholder Update

Written by Customer Service on May 25, 2023. Posted in Public Companies.

Updates Have Been Released to Shareholders Regarding the Company’s Progress Through May 25, 2023 ESCONDIDO, CA, May 25, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — eWorld Companies, Inc. (OTC: EWRC) has issued a Shareholders’ Update, providing valuable insights into the company’s progress thus far. Mr. Gorny, the company’s spokesperson, expressed his enthusiasm, stating, “We are thrilled to share this announcement. Similar to numerous other businesses, we faced significant challenges and unforeseen delays caused by the impact of Covid, post-Covid recovery, and supply chain disruptions. However, we utilized that time effectively to refine our goals and objectives, update our financials and filings, and make necessary adjustments to our infrastructure. With those obstacles now behind us, we are fully...

Barletta Pontoon Boats Extends Popular Customer Service Holiday Hotline for Entire Summer Boating Season

Written by Customer Service on May 25, 2023. Posted in Public Companies.

EDEN PRAIRIE, Minn., May 25, 2023 (GLOBE NEWSWIRE) — With one of the biggest boating weekends right around the corner, Barletta Pontoon Boats, a premium pontoon boat manufacturer, announced that its popular customer service holiday hotline will extend beyond its typical Memorial Day weekend hours and will now be available all summer to any Barletta owner. The new summer season helpline is the boating industry’s first-ever, manufacturer-resourced hotline. “The holiday hotlines have been an enormous hit with Barletta owners across the nation,” said Jeff Haradine, president of Barletta Pontoon Boats. “Ensuring our customers have a great experience with our products on and off the water is the foundation for everything we do. I’m proud of our team for continuing to look for innovative ways to improve the customer experience, ensuring...

Month: May 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals